Nearly all Medicare Advantage insurers report that the business is not profitable, and a majority intend to scale back supplemental benefits for 2027. That pressure persists even after the Centers for Medicare and Medicaid Services finalized a 2.48% average payment increase for the coming year, a figure that projects more than $13 billion in added payments. The gap between what CMS is willing to pay and what plans say they need to stay solvent now shapes the benefits that tens of millions of seniors will see when open enrollment begins this fall.
Why the 2.48% rate increase falls short for most carriers
CMS initially proposed a net average increase of just 0.09% for 2027 Medicare Advantage and Part D plans, a near-flat figure that alarmed insurers and industry groups alike. After a public comment period, the agency revised the number sharply upward. The final 2027 rate announcement settled on a projected average increase of 2.48%, incorporating adjustments for star ratings, effective growth rates, and revised risk models.
A 2.48% bump sounds meaningful in isolation. But for carriers already reporting operating losses on their Medicare Advantage books, that increase may not cover rising medical costs, utilization trends, and the administrative expenses tied to CMS coding and audit requirements. When 93% of insurers describe the line of business as unprofitable, the math behind 2027 benefit design becomes straightforward: plans will trim extras to close the gap.
The extras at risk are the supplemental benefits that have made Medicare Advantage popular with enrollees, including dental coverage, vision care, hearing aids, gym memberships, transportation, meal supports, and over-the-counter allowances. These are not required by statute. Plans fund them from the difference between their CMS payments and their projected medical costs. When that margin shrinks, supplemental benefits are the first line item to be cut, often before carriers increase premiums or narrow networks.
Insurers also face headwinds that a single-digit rate increase cannot fully offset. Medical inflation has accelerated, particularly for hospital and post-acute care. Utilization has risen as members resume deferred procedures and as more complex, high-cost therapies enter the market. At the same time, CMS has tightened scrutiny on risk adjustment coding and prior authorization practices, raising compliance costs and dampening some of the revenue growth that plans once relied on to fund rich benefit packages.
CMS rate-setting documents and what they reveal
The strongest public evidence on 2027 payment levels comes directly from CMS. The agency’s advance notice, published earlier in the rate-setting cycle, laid out the components driving the initial 0.09% proposal: the effective growth rate, star ratings impact, risk model normalization, and restrictions on certain diagnosis sources. Each of those levers affects how much money flows to individual plans, even when the overall average appears modest.
The final rate announcement then revised the projection to 2.48%, reflecting more than $13 billion in total payments. CMS framed the update as a step toward “strengthening accountability and long-term sustainability,” according to the agency’s press materials accompanying the final policies. That language signals a focus on payment accuracy and coding integrity rather than preserving current benefit levels or plan margins.
Historically, CMS has published its annual Medicare Advantage updates, including advance notices, final announcements, and technical appendices, through a central collection of official rate documents. Those materials explain the formulas and assumptions behind the national averages but do not disclose how any single carrier’s profitability is affected. Instead, they describe program-wide trends and the policy rationale for adjusting risk scores, quality bonuses, and benchmarks.
The 93% profitability figure and benefit-reduction intentions, however, do not appear in any CMS document. They originate from industry surveys and secondary reporting that aggregate carriers’ self-reported financial experience and strategic plans. No primary dataset from CMS, and no publicly available bid-level filing, currently quantifies how many carriers consider the business unprofitable or specifies which supplemental benefits will be cut in 2027. The public record therefore consists of two parallel narratives: CMS emphasizing sustainable, accurate payments, and insurers warning that those payments are insufficient to maintain today’s level of extras.
What seniors should expect in 2027
For beneficiaries, the policy debate will show up in plan comparison charts rather than in rate notices. Many carriers are expected to reduce or tighten popular supplemental offerings: dental benefits with lower annual maximums, vision and hearing coverage with higher copays, smaller over-the-counter allowances, or stricter eligibility rules for transportation and meal programs. Some plans may introduce or increase monthly premiums, while others may preserve zero-premium status but offset it with narrower networks or higher cost-sharing for specialist visits and hospital stays.
Not every market will move in the same direction. Large national insurers with diversified revenue streams may absorb short-term losses in highly competitive regions to protect market share, while smaller or regional plans could exit counties where margins are thin. In some areas, beneficiaries may see fewer plan choices on the Medicare Advantage menu, even as remaining options continue to advertise added benefits compared with traditional Medicare.
As 2027 approaches, seniors and caregivers will need to pay closer attention to the details behind marketing slogans. The headline promise of dental or vision coverage may mask reduced annual limits or narrower provider lists. The combination of modest CMS payment growth, heightened regulatory oversight, and widespread reports of unprofitability suggests that the era of steadily richer Medicare Advantage extras is giving way to a more constrained, trade-off-driven phase-one where each new benefit enhancement is likely balanced by a cut somewhere else in the package.
